Trial intelligence / Profile preview

iPACK Block vs PAI as Adjunct to FTB in TKA

NCT07267650Not yet recruiting

Sponsor
Turgutlu State Hospital
Start
Jan 2026
Primary completion
Jun 2026
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Turgutlu State Hospital. Primary endpoint: Postoperative Pain Score with Movement at 48 hours. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07267650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07267650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call